Lipoproteins as carriers of pharmacological agents:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
Dekker
1991
|
Schriftenreihe: | Targeted diagnosis and therapy
5 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XI, 404 S. Ill. |
ISBN: | 0824785053 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004704159 | ||
003 | DE-604 | ||
005 | 20130613 | ||
007 | t | ||
008 | 920203s1991 a||| |||| 00||| engod | ||
020 | |a 0824785053 |9 0-8247-8505-3 | ||
035 | |a (OCoLC)23732143 | ||
035 | |a (DE-599)BVBBV004704159 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 |a DE-29 |a DE-188 | ||
050 | 0 | |a RS201.L53 | |
082 | 0 | |a 615/.19 |2 20 | |
084 | |a VX 8560 |0 (DE-625)147831:253 |2 rvk | ||
084 | |a XI 1800 |0 (DE-625)152978:12905 |2 rvk | ||
245 | 1 | 0 | |a Lipoproteins as carriers of pharmacological agents |c ed. by J. Michael Shaw |
264 | 1 | |a New York [u.a.] |b Dekker |c 1991 | |
300 | |a XI, 404 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Targeted diagnosis and therapy |v 5 | |
650 | 4 | |a Lipoprotéines vectrices de médicaments | |
650 | 4 | |a Drug Carriers | |
650 | 4 | |a Lipoprotein drug carriers | |
650 | 4 | |a Lipoproteins |x administration & dosage | |
650 | 0 | 7 | |a Trägersubstanz |0 (DE-588)4131813-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lipoproteide |0 (DE-588)4074259-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Lipoproteide |0 (DE-588)4074259-3 |D s |
689 | 0 | 1 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Lipoproteide |0 (DE-588)4074259-3 |D s |
689 | 1 | 1 | |a Wirkstofffreisetzung |0 (DE-588)4190018-2 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Lipoproteide |0 (DE-588)4074259-3 |D s |
689 | 2 | 1 | |a Trägersubstanz |0 (DE-588)4131813-4 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Shaw, J. M. |e Sonstige |4 oth | |
830 | 0 | |a Targeted diagnosis and therapy |v 5 |w (DE-604)BV000844352 |9 5 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002889977&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-002889977 |
Datensatz im Suchindex
_version_ | 1804118820895326208 |
---|---|
adam_text | AS CARRIERS OF PHARMACOLOGICAL AGENTS EDITED DY J. MICHAEL SHAW STERLING
DRUG INC. MALVERN, PENNSYLVANIA MARCEL DEKKER, INC. NEW YORK * BASEL *
HONG KONG CONTENTS INTRODUCTION TO THE SERIES PREFACE CONTRIBUTORS
CHAPTER 1 CHAPTER 2 CHAPTER 3 CHAPTER 4 CHAPTER 5 III V IX LIPOPROTEINS
IN BIOLOGICAL FLUIDS AND COMPARTMENTS: SYNTHESIS, INTERCONVERSIONS, AND
CATABOLISM 1 DAVID K. SPADY CELLULAR INTERACTIONS OF LIPOPROTEINS WITH
THE VASCULAR ENDOTHELIUM: ENDOCYTOSIS AND TRANSCYTOSIS 45 NICOLAE
SIMIONESCU AND MAYA SIMIONESCU TECHNIQUES FOR COMPLEXING PHARMACOLOGICAL
AGENTS TO LIPOPROTEINS AND LIPID MICROEMULSIONS 97 BO LUNDBERG
LIPOPROTEINS AND MICROEMULSIONS AS CARRIERS OF THERAPEUTIC AND CHEMICAL
AGENTS 141 ALEXANDER T. FLORENCE AND GAVIN W. HALBERT LIPOPROTEINS,
MALIGNANCY, AND ANTICANCER AGENTS CURT PETERSON, MICHELE MASQUELIER,
MATS RUDLING, KRISTINA SB DERBERG, AND SIGURD VITOLS 175 VLL VIIL
CONTENTS CHAPTER 6 ACETYLATED LOW DENSITY LIPOPROTEIN AND THE DELIVERY
OF IMMUNOMODULATORS TO MACROPHAGES 201 MARK S. RUTHERFORD, W. STEWART
FUTCH, JR., AND LAWRENCE B. SCHOOK CHAPTER 7 RECEPTOR-DEPENDENT
TARGETING OF LIPOPROTEINS TO SPECIFIC CELL TYPES OF THE LIVER 225 THEO
J. C. VAN BERKEL, J. KAR KRUIJT, P. CHRIS DE SMIDT, AND MARTIN K.
BIJSTERBOSCH CHAPTER 8 LIPOPROTEINS AS CARRIERS FOR ORGAN-IMAGING
RADIOPHARMACEUTICALS 251 RAYMOND E. COUNSELL, SUSAN W. SCHWENDNER, LAURA
E. DEFORGE, MARK R. DEGALAN, AND ROGER S. NEWTON CHAPTER 9 IN VIVO
APPLICATION OF LIPOPROTEINS AS DRUG CARRIERS: PHARMACOLOGICAL EVALUATION
OF STERYLGLUCOSIDE-LIPOPROTEIN COMPLEXES 315 MAKOTO SUGIYAMA AND JUNZO
SEKI CHAPTER 10 KEY ISSUES IN THE DELIVERY OF PHARMACOLOGICAL AGENTS
USING LIPOPROTEINS: DESIGN OF A SYNTHETIC APOPROTEIN- LIPID CARRIER 351
/. MICHAEL SHAW AND KALA V. SHAW INDEX 385
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV004704159 |
callnumber-first | R - Medicine |
callnumber-label | RS201 |
callnumber-raw | RS201.L53 |
callnumber-search | RS201.L53 |
callnumber-sort | RS 3201 L53 |
callnumber-subject | RS - Pharmacy |
classification_rvk | VX 8560 XI 1800 |
ctrlnum | (OCoLC)23732143 (DE-599)BVBBV004704159 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02167nam a2200553 cb4500</leader><controlfield tag="001">BV004704159</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130613 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920203s1991 a||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824785053</subfield><subfield code="9">0-8247-8505-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)23732143</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004704159</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS201.L53</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 8560</subfield><subfield code="0">(DE-625)147831:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1800</subfield><subfield code="0">(DE-625)152978:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lipoproteins as carriers of pharmacological agents</subfield><subfield code="c">ed. by J. Michael Shaw</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 404 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Targeted diagnosis and therapy</subfield><subfield code="v">5</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoprotéines vectrices de médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Carriers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoprotein drug carriers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">administration & dosage</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Trägersubstanz</subfield><subfield code="0">(DE-588)4131813-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipoproteide</subfield><subfield code="0">(DE-588)4074259-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lipoproteide</subfield><subfield code="0">(DE-588)4074259-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lipoproteide</subfield><subfield code="0">(DE-588)4074259-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4190018-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Lipoproteide</subfield><subfield code="0">(DE-588)4074259-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Trägersubstanz</subfield><subfield code="0">(DE-588)4131813-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shaw, J. M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Targeted diagnosis and therapy</subfield><subfield code="v">5</subfield><subfield code="w">(DE-604)BV000844352</subfield><subfield code="9">5</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002889977&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002889977</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV004704159 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:16:23Z |
institution | BVB |
isbn | 0824785053 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002889977 |
oclc_num | 23732143 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
physical | XI, 404 S. Ill. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | Dekker |
record_format | marc |
series | Targeted diagnosis and therapy |
series2 | Targeted diagnosis and therapy |
spelling | Lipoproteins as carriers of pharmacological agents ed. by J. Michael Shaw New York [u.a.] Dekker 1991 XI, 404 S. Ill. txt rdacontent n rdamedia nc rdacarrier Targeted diagnosis and therapy 5 Lipoprotéines vectrices de médicaments Drug Carriers Lipoprotein drug carriers Lipoproteins administration & dosage Trägersubstanz (DE-588)4131813-4 gnd rswk-swf Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf Lipoproteide (DE-588)4074259-3 gnd rswk-swf Wirkstofffreisetzung (DE-588)4190018-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Lipoproteide (DE-588)4074259-3 s Arzneistoffträger (DE-588)4278196-6 s DE-604 Wirkstofffreisetzung (DE-588)4190018-2 s Trägersubstanz (DE-588)4131813-4 s Shaw, J. M. Sonstige oth Targeted diagnosis and therapy 5 (DE-604)BV000844352 5 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002889977&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Lipoproteins as carriers of pharmacological agents Targeted diagnosis and therapy Lipoprotéines vectrices de médicaments Drug Carriers Lipoprotein drug carriers Lipoproteins administration & dosage Trägersubstanz (DE-588)4131813-4 gnd Arzneistoffträger (DE-588)4278196-6 gnd Lipoproteide (DE-588)4074259-3 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd |
subject_GND | (DE-588)4131813-4 (DE-588)4278196-6 (DE-588)4074259-3 (DE-588)4190018-2 (DE-588)4143413-4 |
title | Lipoproteins as carriers of pharmacological agents |
title_auth | Lipoproteins as carriers of pharmacological agents |
title_exact_search | Lipoproteins as carriers of pharmacological agents |
title_full | Lipoproteins as carriers of pharmacological agents ed. by J. Michael Shaw |
title_fullStr | Lipoproteins as carriers of pharmacological agents ed. by J. Michael Shaw |
title_full_unstemmed | Lipoproteins as carriers of pharmacological agents ed. by J. Michael Shaw |
title_short | Lipoproteins as carriers of pharmacological agents |
title_sort | lipoproteins as carriers of pharmacological agents |
topic | Lipoprotéines vectrices de médicaments Drug Carriers Lipoprotein drug carriers Lipoproteins administration & dosage Trägersubstanz (DE-588)4131813-4 gnd Arzneistoffträger (DE-588)4278196-6 gnd Lipoproteide (DE-588)4074259-3 gnd Wirkstofffreisetzung (DE-588)4190018-2 gnd |
topic_facet | Lipoprotéines vectrices de médicaments Drug Carriers Lipoprotein drug carriers Lipoproteins administration & dosage Trägersubstanz Arzneistoffträger Lipoproteide Wirkstofffreisetzung Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002889977&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000844352 |
work_keys_str_mv | AT shawjm lipoproteinsascarriersofpharmacologicalagents |